Peptides & Peptide Synthesis Products

Cl-HOBt

Cl-HOBt

$21.00
$21.00
Cl-HOBt, Catalog No: 31004
6-Cl-HOBt, 6-Chloro-1-hydroxybenzotriazole, HOBt alternative, CAS: 26198-19-6, MW: 169.57, Formula: C6H4ClN3O
Catalog No: 31004
6-Cl-HOBt, 6-Chloro-1-hydroxybenzotriazole, HOBt alternative, CAS: 26198-19-6, MW: 169.57, Formula: C6H4ClN3O

* Required Fields

Description

Details

6-Cl-HOBt, 6-Chloro-1-hydroxybenzotriazole, HOBt alternative
Additional Information

Additional Information

Catalog Number 31004
CAS 26198-19-6
M.W. 169.57
Formula C6H4ClN3O
IUPAC Name 6-chloro-1-hydroxybenzotriazole
Synonym 6-Cl-HOBt, 6-Chloro-1-hydroxybenzotriazole, HOBt alternative
Also Known As
  • 6-chloro-1-hydroxybenzotriazole
  • 6-chloro-1-hydroxy-benzotriazole
  • 26198-19-6
  • ZINC02570270
  • NSC30573
  • STOCK2S-28309
  • 39785_FLUKA
  • 6-Chloro-1-hydroxybenzotriazole dihydrate
  • Cl-HOBt
InChIKey TZCYLJGNWDVJRA-UHFFFAOYSA-N
InChI InChI=1S/C6H4ClN3O/c7-4-1-2-5-6(3-4)10(11)9-8-5/h1-3,11H
SMILES C1=CC2=C(C=C1Cl)N(N=N2)O
Cited Uses

Details

1. Chang YS et al, "Stapled ?-helical peptide drug development: A potent dual inhibitor of MDM2 and MDMX for p53-dependent cancer therapy", Proceedings of the National Academy of Sciences of the United States of America, 110(36) pp.E3445-E3454 (2013 Sep 3).
2. Shen D et al, "Evaluation of Phage Display Discovered Peptides as Ligands for Prostate-Specific Membrane Antigen (PSMA)", PLoS ONE, 8(7) pp.e68339 ().
3. Morellato-Castillo L et al, "Interfacial cavity filling to optimize CD4-mimetic miniprotein interactions with the HIV-1 surface protein", Journal of medicinal chemistry, 56(12) pp.10.1021/jm4002988 (2013 Jun 27).
4. Finan B et al, "Targeted estrogen delivery reverses the metabolic syndrome", Nature medicine, 18(12) pp.1847-1856 (2012 Dec).
5. Wang YC et al, "Solid-Phase Synthesis of C-Terminal Peptide Libraries for Studying the Specificity of Enzymatic Protein Prenylation", Chemical communications (Cambridge, England), 48(66) pp.8228-8230 (2012 Aug 25).
6. Fruchart-Gaillard C et al, "Engineering of Three-Finger Fold Toxins Creates Ligands with Original Pharmacological Profiles for Muscarinic and Adrenergic Receptors", PLoS ONE, 7(6) pp.e39166 ().
7. Berezowska I et al, "Novel TIPP (H-Tyr-Tic-Phe-Phe-OH) analogues displaying a wide range of efficacies at the ? opioid receptor. Discovery of two highly potent and selective ? opioid agonists", Bioorganic & medicinal chemistry letters, 22(5) pp.1899-1902 (2012 Mar 1).
8. Rao V et al, "A Sucrose-derived Scaffold for Multimerization of Bioactive Peptides", Bioorganic & medicinal chemistry, 19(21) pp.6474-6482 (2011 Nov 1).
9. Cai M et al, "Utilize conjugated melanotropins for the earlier diagnosis and treatment of Melanoma", European journal of pharmacology, 660(1) pp.188-193 (2011 Jun 11).
10. Alleti R et al, "A Solanesol-derived Scaffold for Multimerization of Bioactive Peptides", The Journal of organic chemistry, 75(17) pp.5895-5903 (2010 Sep 3).
11. Yamamoto T et al, "Biological and Conformational Evaluation of Bifunctional Compounds for Opioid Receptor Agonists and Neurokinin 1 Receptor Antagonists Possessing Two Penicillamines", Journal of medicinal chemistry, 53(15) pp.5491-5501 (2010 Aug 12).
12. Mayorov AV et al, "Solid-Phase Peptide Head-to-Side Chain Cyclodimerization: Discovery of C2-Symmetric Cyclic Lactam Hybrid ?-Melanocyte-Stimulating Hormone (MSH)/Agouti-Signaling Protein (ASIP) Analogues with Potent Activities at the Human Melanocortin Receptors", Peptides, 31(10) pp.1894-1905 (2010 Oct).
13. Lee S et al, "Solution structure of GxTX-1E, a high affinity tarantula toxin interacting with voltage sensors in Kv2.1 potassium channels", Biochemistry, 49(25) pp.5134-5142 (2010 Jun 29).
14. Becker GL et al, "Potent inhibitors of furin and furin-like proprotein convertases containing decarboxylated P1 arginine mimetics", Journal of medicinal chemistry, 53(3) pp.1067-1075 (2010 Feb 11).
15. Wakata A et al, "Simultaneous Fluorescent Monitoring of Proteasomal Subunit Catalysis", Journal of the American Chemical Society, 132(5) pp.1578 (2010 Feb 10).
16. Yamamoto T et al, "Improving Metabolic Stability By Glycosylation: Bifunctional Peptide Derivatives That Are Opioid Receptor Agonists and Neurokinin 1 Receptor Antagonists", Journal of medicinal chemistry, 52(16) pp.5164-5175 (2009 Aug 27).
17. Yamamoto T et al, "The Biological Activity and Metabolic Stability of Peptidic Bifunctional Compounds That Are Opioid Receptor Agonists and Neurokinin 1 Receptor Antagonists with A Cystine Moiety", Bioorganic & medicinal chemistry, 17(20) pp.7337-7343 (2009 Oct 15).
18. Qu H et al, "Substitution of Arginine with Proline and Proline Derivatives in Melanocyte-Stimulating Hormones Leads to Selectivity for Human Melanocortin 4 Receptor", Journal of medicinal chemistry, 52(12) pp.3627-3635 (2009 Jun 25).
19. Josan JS et al, "Solid-Phase Synthesis of Heterobivalent Ligands Targeted to Melanocortin and Cholecystokinin Receptors", International journal of peptide research and therapeutics, 14(4) pp.293-300 (2008 Dec).
20. Yamamoto T et al, "The Importance of Micelle-Bound States for the Bioactivities of Bifunctional Peptide Derivatives for ?/? Opioid Receptor Agonists and Neurokinin 1 Receptor Antagonists", Journal of medicinal chemistry, 51(20) pp.6334-6347 (2008 Oct 23).
21. Yamamoto T et al, "A Structure-Activity Relationship Study and Combinatorial Synthetic Approach of C-Terminal Modified Bifunctional Peptides That Are ?/? Opioid Receptor Agonists and Neurokinin 1 Receptor Antagonists", Journal of medicinal chemistry, 51(5) pp.1369-1376 (2008 Mar 13).
22. Mayorov AV et al, "Structure-Activity Relationships of Cyclic Lactam Analogues of ?-Melanocyte-Stimulating Hormone (?-MSH) Targeting the Human Melanocortin-3 Receptor", Journal of medicinal chemistry, 51(2) pp.187-195 (2008 Jan 24).
23. Mayorov AV et al, "Development of Cyclic ?-MSH Analogues with Selective hMC3R Agonist and hMC3R/hMC5R Antagonist Activities", Journal of medicinal chemistry, 49(6) pp.1946-1952 (2006 Mar 23).
Reviews
cr